RBC Capital analyst Mandeep Jagpal maintained a Sell rating on abrdn (ABDN – Research Report) today and set a price target of p135.00. The ...

Barry Callebaut (SIX: BARN) reported lower sales volume in the first quarter of their 2025 fiscal year, as expected by the ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

Underperforming since the calendar turned, "munis have continued to cheapen over the past three weeks as Treasury returns are about flat for the year while munis are down 0.31%," said Jason Wong, vice ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently executed a stock transaction involving the sale of company shares. According to a filing with ...

U.S. stock trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

In a report released today, Adam Jonas from Morgan Stanley maintained a Buy rating on Ferrari (RACE – Research Report), with a price target of ...